Glenmede Investment Management’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$13.2M Sell
161,343
-988
-0.6% -$85.6K 0.06% 278
2025
Q2
$14.8M Buy
+162,331
New +$14.5M 0.07% 252

Other funds holding DOX

Glenmede Investment Management's DOX Position: Q3 2025 in Review

Glenmede Investment Management reduced its Amdocs (DOX) stake by 0.61% in Q3 2025, selling an estimated $85.6K and leaving 161,343 shares worth $13.2M. The position accounts for 0.06% of the portfolio, ranked #278.

Glenmede Investment Management first reported a position in DOX in Q2 2025 and has held it in 2 quarters since. The position peaked at $14.8M in Q2 2025. 526 funds tracked by Wall St. Rank hold DOX as of Q3 2025.

  • Glenmede Investment Management held 161,343 shares of Amdocs worth $13.2M as of Q3 2025.
  • Glenmede Investment Management sold 988 Amdocs shares in Q3 2025, an estimated $85.6K.
  • Amdocs made up 0.06% of Glenmede Investment Management's portfolio in Q3 2025, its #278 holding.
  • Glenmede Investment Management first reported a position in Amdocs in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Amdocs position peaked at $14.8M in Q2 2025.
  • 526 funds tracked by Wall St. Rank held Amdocs as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.